Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded Healthcare sector company. As of May 21, 2026, MTNB trades at $0.59 with a market cap of $3.46M and a P/E ratio of -0.30. MTNB moved +14.52% today. Year to date, MTNB is -0.64%; over the trailing twelve months it is -16.08%. Its 52-week range spans $0.47 to $4.25. Rallies surfaces MTNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own MTNB include Highbridge Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Matinas BioPharma Holdings, Inc..
| Metric | Value |
|---|---|
| Price | $0.59 |
| Market Cap | $3.46M |
| P/E Ratio | -0.30 |
| EPS | $-2.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.25 |
| 52-Week Low | $0.47 |
| Volume | 312.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.35M |
| Gross Margin | 0.00% |
MTNB analyst coverage data. Average price target: $0.00.